Aggressive medical care may not be all that useful in men suffering from pneumonia as they are more likely to die from the disease than their female counterparts, a new study led by an Indian scientist has found.
Sachin Yende, M.D., study co-author and assistant professor in the Department of Critical Care Medicine, University of Pittsburgh School of Medicine said that men were more prone to die up to a year after pneumonia, despite adjusting for health behaviours and chronic conditions.
"It is well known that women live longer than men. We have always assumed that these differences occur because men engage in riskier behaviors and have a greater burden of chronic diseases," said Yende.
"Our study showed that men were more likely to die up to a year after pneumonia, despite adjusting for health behaviours and chronic conditions. Further, our findings indicate this may be linked to differences in immune response," he added.
For the study, the University of Pittsburgh researchers evaluated data from 1,136 men and 1,047 women with symptoms of pneumonia who were treated at 28 hospital emergency departments in the United States.
On average, men arrived at the emergency departments with poorer vital signs, were more likely to be smokers and had a greater variety of complicating health conditions.
fter hospitalization, men received timely antibiotic treatments more often than women and were twice as likely to be admitted immediately to intensive-care units.
"The gender disparity on aggressiveness of hospital care is appropriate, given that men tended to be significantly sicker than women," said Michael Reade, D.Phil., first author, former fellow in Pitt's Department of Critical Care Medicine, and assistant professor at the University of Melbourne, Australia.
Investigators adjusted results for age, race, tobacco use, other demographic characteristics, chronic health conditions, health behaviors and levels of treatment.
"Even so, men had a 30 percent higher risk of death, and the social factors we examined were not sufficient to explain the differences we observed," Reade said.
Using the patient data, Drs. Reade, Yende and their colleagues next examined a series of molecules important to the body's immune response to infection, finding significant differences between men and women in levels of tumor necrosis factor, interleukin-6, interleukin-10, antithrombin III, Factor IX, plasminogen activator inhibitor-1 and D-dimer. By comparison between the genders, some concentrations were lower, while others were higher.
"No one had shown this before. So these differences in immune response could explain at least some of the differences in survival," said Yende.
Gender differences in immune response to infection are an area of intensive research, with investigations into the role of X chromosomes, which encode genes for several important immune system mediators.
"Some investigators have suggested that the immune response may differ because women have two copies of the X chromosome. Sex hormones are another area of inquiry. It is tempting to speculate that in the future, medical treatment of pneumonia may be different for men and women," said Yende.
The study will be presented at the 104th International Conference of the American Thoracic Society.